| |||||||||
We don't have a Bulls article about Pfizer (PFE)/Wyeth (WYE) yet.
You could be the first person to write a bullish analysis about Pfizer (PFE)/Wyeth (WYE). As the first editor, you could earn a "Top Contributor" spot if you have an account.
Wyeth has nine drugs currently filed for registration, if these drugs receive approval they should provide a boost the company's earnings in the near future.
Wyeth's operations have broad exposure to rapidly growing international markets. The company's Consumer Healthcare and Nutritional divisions have a particularly high concentration in emerging markets. Because of its international presence, Wyeth stands to benefit a a weakening dollar and the rising of developing countries.
Wyeth currently stands as the world's fourth largest biotechnology company. Its focus on this promising, high growth area of medicine makes it more attractive than its pharmaceutical peers.
| ||||||
|
|
